Late-stage pharmaceutical R&D and pricing policies under two-stage regulation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Late-stage pharmaceutical R&D and pricing policies under two-stage regulation

Published:2016-12 Issue: Volume:50 Page:298-311
ISSN:0167-6296
Container-title:Journal of Health Economics
language:en
Short-container-title:Journal of Health Economics

Author:

Jobjörnsson Sebastian,Forster Martin,Pertile Paolo,Burman Carl-Fredrik

Funder

European Union Seventh Framework Programme

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference47 articles.

1. Market size in innovation: theory and evidence from the pharmaceutical industry;Acemoglu;The Quarterly Journal of Economics,2004

2. Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study;Aitken;American Journal of Respiratory and Critical Care Medicine,2012

3. The patents-based pharmaceutical development process: rationale, problems, and potential reforms;Barton;JAMA: The Journal of the American Medical Association,2005

4. Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study;Bilton;European Respiratory Journal,2011

5. Toward a functional definition of a ‘rare disease’ for regulatory authorities and funding agencies;Clarke;Value in Health,2014

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Timely, Cheap, or Risk-Free? The Effect of Regulation on the Price and Availability of New Drugs;Pharmacy;2024-03-18

2. Pricing Personalised Drugs: Comparing Indication Value Based Prices with Performance Based Schemes;The B.E. Journal of Economic Analysis & Policy;2024-03-07

3. The price of cost-effectiveness thresholds under therapeutic competition in pharmaceutical markets;Journal of Health Economics;2023-07

4. Value-Based Clinical Trials: Selecting Recruitment Rates and Trial Lengths in Different Regulatory Contexts;Management Science;2022-09-20

5. R&D and market size: Who benefits from orphan drug legislation?;Journal of Health Economics;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3